Jamie Irvine is a journalist for The Medicine Maker, covering a wide range of topics in the pharmaceutical industry. With a focus on drug discovery, regulation, and emerging technologies, Jamie's articles provide insights into the latest advancements and challenges in the field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Jamie's articles predominantly focus on healthcare, pharmaceuticals, and scientific research. Given this emphasis, she would likely be interested in pitches offering expert commentary or insights related to medical research, drug discovery, FDA regulations, genetic engineering or disease treatment.
The high percentage of industry-specific content and expert commentary suggests that Jamie is receptive to detailed analysis from experts in the field. Therefore, when reaching out to her it's important to offer well-researched and specialized information pertinent to these topics.
Since there is no specific geographic focus mentioned for Jamie Irvine’s coverage area, pitches should aim at providing international relevance rather than being confined to a particular region.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Introducing the British Standards Institution's new environmental initiative to minimize antimicrobial resistance caused by manufacturing operations.
Researchers have designed a “mini gene” therapy that could hold promise for treating Usher Syndrome Type 1F
Researchers repurpose α-difluoromethylornithine as oral medication for type 1 diabetes
The world's first clinical trial for a Hunter syndrome gene therapy opens in Manchester
Charting the decline of Beethoven's hearing, considering the music he never heard, and asking a controversial question…
What matters most in music composition – hearing or sight? Though hearing might make the most sense, Beethoven’s progressive deafness is proof that a great imagination can be enough to create remarkable music – and there are a handful of famous composers who struggled to create after experiencing loss of sight.
A look at the composers that lost their sight What matters most in music composition – hearing or sight?
Researchers target glycocalyx to halt diabetic retinopathy and kidney disease Jamie Irvine | | News
Preparing for the EU's new HTA regulation and Joint Clinical Assessment process
Experts discuss the most exciting Alzheimer’s Disease treatment trends – and make bold predictions for the future. Read more here
(833) 317-6278 
